Sharon Bio-Medicine Ltd. reports unaudited earnings results for the quarter and half year ended September 30, 2020. For the quarter, revenue from operations were INR 432.54 million against INR 420.342 million reported a year ago. Profit for the period was INR 23.743 million against INR 45.851 million reported a year ago. Basic EPS was 0.20 against INR 0.39 reported a year ago. For the six months, revenue from operations were INR 790.56 million against INR 861.40 million reported a year ago. Profit for the period was INR 38.736 million against loss of INR 641.34 million reported a year ago. Basic EPS was 0.33 against INR 0.78 reported a year ago.